U.S. Dermatology Devices Market Analysis Report – Trends, Forecasts, and Key Insights

The U.S. dermatology devices market is set to experience significant growth, with a projected value of USD 12.73 billion by 2030. This growth is driven by technological advancements in dermatology devices and the increasing prevalence of skin disorders in the country. With over 50 million people affected by skin conditions annually, the demand for effective treatments is on the rise.

One of the key factors contributing to this market growth is the development of innovative medical devices that offer less invasive and more efficient treatments. Companies like Cytrellis, Inc. have received FDA approval for products like Ellacor, which utilize advanced technology to deliver skin treatments that are less painful and non-scarring.

Moreover, the growing awareness about the importance of early diagnosis and treatment of skin disorders is also fueling market growth. As disposable income in the U.S. increases, there is a corresponding rise in expenditure on non-essential skin treatments such as skin tightening and resurfacing.

The impact of the pandemic has also been significant, with more than 75% of plastic surgery practices reporting increased business, and a surge in demand for dermatology services due to negative body image perceptions. This has led to a boost in the dermatology devices market, with treatment devices leading the way in revenue generation.

Overall, the U.S. dermatology devices market is poised for substantial growth, with key players like Cutera, Inc., Candela Medical Corporation, and Bausch Health Companies Inc. driving innovation in the industry. With a focus on delivering effective and less invasive treatments, the market is set to witness continued expansion in the coming years.